AUSTIN, Texas, March 27, 2017 — Genprex, Inc., a privately held, clinical-stage biopharmaceutical company developing immunogene therapeutics, today announced that Julien Pham, MD, the Company’s Chief Operating Officer, is scheduled to present a corporate overview at two upcoming healthcare investor conferences. Sachs 5th Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 at 3:00 PM EDT in New York, NY BioCentury 24th Annual […]